Histogen Inc:医療機器:M&Aディール及び事業提携情報

◆英語タイトル:Histogen Inc - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA904C6470
◆発行会社(調査会社):GlobalData
◆発行日:2018年10月
◆ページ数:21
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Histogen Inc (Histogen) is a regenerative medicine company that develops novel therapies based on the products of cells grown under simulated embryonic conditions. The company’s products include a soluble multipotent cell conditioned media and insoluble extracellular matrix. Its products are used in various applications, which include soft tissue augmentation, hair regrowth, skincare, orthopedics and wound care. The company’s development pipeline also includes hair stimulating complex (HSE660), exceltrix and extracellular matrix. Its technology concentrates on stimulating a patient’s own stem cells by delivering a complex of multipotent human proteins that support stem cell growth and differentiation. Histogen is headquartered in San Diego, California, the US.

Histogen Inc – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Histogen Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Histogen Inc, Medical Equipment Deals By Type, 2012 to YTD 2018 6
Histogen Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Histogen Inc, Medical Equipment, Deals By Market, 2012 to YTD 2018 8
Histogen Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
Histogen Inc, Medical Equipment, Deal Details 10
Venture Financing 10
Histogen Raises USD6 Million in Series D Round of Financing 10
Histogen to Raise USD18 Million in Venture Financing 11
Partnerships 12
Suneva Medical Amends Licensing Agreement With Histogen 12
Suneva Medical Enters Into Licensing Agreement With Histogen For CCM-Based Aesthetic Products 13
Histogen Forms Joint Venture with Wylde 14
Histogen Enters Into Joint Venture To Form Pur Biologics 15
Acquisition 16
Stratus Media To Acquire Histogen, Pharma Company 16
Histogen Inc – Key Competitors 17
Histogen Inc – Key Employees 18
Histogen Inc – Locations And Subsidiaries 19
Head Office 19
Other Locations & Subsidiaries 19
Joint Venture 19
Recent Developments 20
Corporate Communications 20
Mar 27, 2018: Histogen Names Dr. David Crean As Board Director 20
Appendix 21
Methodology 21
About GlobalData 21
Contact Us 21
Disclaimer 21

List of Tables
Histogen Inc, Medical Equipment, Key Facts 2
Histogen Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 2
Histogen Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Histogen Inc, Medical Equipment Deals By Type, 2012 to YTD 2018 6
Histogen Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Histogen Inc, Deals By Market, 2012 to YTD 2018 8
Histogen Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
Histogen Raises USD6 Million in Series D Round of Financing 10
Histogen to Raise USD18 Million in Venture Financing 11
Suneva Medical Amends Licensing Agreement With Histogen 12
Suneva Medical Enters Into Licensing Agreement With Histogen For CCM-Based Aesthetic Products 13
Histogen Forms Joint Venture with Wylde 14
Histogen Enters Into Joint Venture To Form Pur Biologics 15
Stratus Media To Acquire Histogen, Pharma Company 16
Histogen Inc, Key Competitors 17
Histogen Inc, Key Employees 18
Histogen Inc, Subsidiaries 19
Histogen Inc, Joint Venture 19

List of Figures
Histogen Inc, Medical Equipment, Deals by Type, 2012 to YTD 2018 2
Histogen Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 2
Histogen Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 2
Histogen Inc, Medical Equipment, Deals By Market, 2012 to YTD 2018 2
Histogen Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Histogen Inc, Medical Equipment, Deals by Type, 2012 to YTD 2018 6
Histogen Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Histogen Inc, Medical Equipment, Deals by Market, 2012 to YTD 2018 8

★海外企業調査レポート[Histogen Inc:医療機器:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • ERHC Energy Inc (ERHE):企業の財務・戦略的SWOT分析
    Summary ERHC Energy Inc (ERHC Energy) is an exploration and production company that explores oil and gas assets. The company possesses deep water oil and gas exploration and production interests in the Gulf of Guinea and onshore interests in Republic of Chad and Republic of Kenya. It holds interests …
  • Cooperative Energy:企業の戦略的SWOT分析
    Cooperative Energy - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and ser …
  • Mentor Graphics Corporation:企業の戦略・SWOT・財務情報
    Mentor Graphics Corporation - Strategy, SWOT and Corporate Finance Report Summary Mentor Graphics Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …
  • Chegg, Inc.:企業のM&A・事業提携・投資動向
    Chegg, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Chegg, Inc. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, ca …
  • Gedeon Richter Plc:企業のM&A・事業提携・投資動向
    Gedeon Richter Plc - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Gedeon Richter Plc Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), d …
  • HTG Molecular Diagnostics Inc (HTGM):企業の財務・戦略的SWOT分析
    Summary HTG Molecular Diagnostics Inc (HTG) is a technology company that provides molecular technology solutions. The company provides products such as HTG edge system, HTG edgeseq reagents and HTG edgeseq immuno-oncology biomarker panel assay, among others. It develops assays and reagent systems th …
  • Creganna Medical:医療機器:M&Aディール及び事業提携情報
    Summary Creganna Medical (Creganna), a subsidiary of TE Connectivity Ltd, formerly known as Creganna-Tactx Medical, is a provider of medical device outsourcing solutions. The company is. It undertakes the design, manufacturing and commercialization of minimally & less invasive delivery and access de …
  • STMicroelectronics NV (STM):医療機器:M&Aディール及び事業提携情報
    Summary STMicroelectronics NV (STM) is a semiconductor company. It develops, manufactures, and markets a wide range of products, including discrete and standard commodity components, full custom devices and semi-custom devices and application-specific standard products, and application-specific inte …
  • Bank of Ireland:戦略・SWOT・企業財務分析
    Bank of Ireland - Strategy, SWOT and Corporate Finance Report Summary Bank of Ireland - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpo …
  • BW Offshore Ltd (BWO):企業の財務・戦略的SWOT分析
    BW Offshore Ltd (BWO) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Quest Diagnostics Inc (DGX)-医療機器分野:企業M&A・提携分析
    Summary Quest Diagnostics Inc (Quest Diagnostics) is a provider of diagnostic information services to patients and physicians through a chain of laboratories and company-owned patient service centers. It offers comprehensive range of services including clinical testing with gene-based and other esot …
  • The AES Corp (AES):企業の財務・戦略的SWOT分析
    The AES Corp (AES) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and th …
  • Atomic Energy of Canada Ltd:企業の戦略的SWOT分析
    Atomic Energy of Canada Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major product …
  • Fenwal Inc-医療機器分野:企業M&A・提携分析
    Summary Fenwal Inc (Fenwal), a subsidiary of Fresenius Kabi AG is a blood technology company that supports transfusion medicine and cell therapies. The company’s products include amicus separator, blood pack units with whole blood filter, mononuclear cell collection, alyx component collection system …
  • Komatsu Ltd.:企業の戦略・SWOT・財務分析
    Komatsu Ltd. - Strategy, SWOT and Corporate Finance Report Summary Komatsu Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate a …
  • Nevro Corp (NVRO):企業の財務・戦略的SWOT分析
    Nevro Corp (NVRO) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • Metabolon Inc-医療機器分野:企業M&A・提携分析
    Summary Metabolon Inc (Metabolon) is a health technology company that develops clinical diagnostic tests for healthcare markets. The company’s products include non-alcoholic steatohepatitis test, GFR test, quantose IGT test, prostarix and prostarix plus tests, among others. Its quantose IR test is a …
  • Gritstone Oncology Inc (GRTS):製薬・医療:M&Aディール及び事業提携情報
    Summary Gritstone Oncology Inc (Gritstone) develops and commercialize tumor-specific cancer immunotherapies. The company’s pipeline product portfolio comprises GRANITE-001, for solid tumors, including metastatic non-small cell lung cancer and gastroesophageal, bladder and colorectal cancers; and SLA …
  • Cholamandalam Investment and Finance Company Ltd (CHOLAFIN):企業の財務・戦略的SWOT分析
    Cholamandalam Investment and Finance Company Ltd (CHOLAFIN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the comp …
  • Talwalkars Better Value Fitness Ltd (TALWALKARS):企業の財務・戦略的SWOT分析
    Talwalkars Better Value Fitness Ltd (TALWALKARS) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key s …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆